217 related articles for article (PubMed ID: 19654554)
41. HLA class II polymorphism in Egyptian children with lymphomas.
Al-Tonbary Y; Abdel-Razek N; Zaghloul H; Metwaly S; El-Deek B; El-Shawaf R
Hematology; 2004 Apr; 9(2):139-45. PubMed ID: 15203870
[TBL] [Abstract][Full Text] [Related]
42. Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.
Skibola CF; Bracci PM; Halperin E; Nieters A; Hubbard A; Paynter RA; Skibola DR; Agana L; Becker N; Tressler P; Forrest MS; Sankararaman S; Conde L; Holly EA; Smith MT
PLoS One; 2008 Jun; 3(7):e2816. PubMed ID: 18636124
[TBL] [Abstract][Full Text] [Related]
43. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
[TBL] [Abstract][Full Text] [Related]
44. Association analysis of genetic variants in the ghrelin and tumor necrosis factor α genes and the risk for non-Hodgkin's lymphoma in Kuwaitis.
Alrashid MH; Al-Serri A; Alshemmari SH; Geo JA; Al-Bustan SA
Cancer Biomark; 2021; 32(1):11-18. PubMed ID: 34024815
[TBL] [Abstract][Full Text] [Related]
45. Genetic variations in CTLA-4, TNF-α, and LTA and susceptibility to T-cell lymphoma in a Chinese population.
Liu J; Liu J; Song B; Wang T; Liu Y; Hao J; Yu J
Cancer Epidemiol; 2013 Dec; 37(6):930-4. PubMed ID: 24035239
[TBL] [Abstract][Full Text] [Related]
46. The effect of LTA gene polymorphisms on cancer risk: an updated systematic review and meta- analysis.
Li J; Wang Y; Chang X; Han Z
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32420584
[TBL] [Abstract][Full Text] [Related]
47. The association between the polymorphisms of TNF-α and non-Hodgkin lymphoma: a meta-analysis.
He YQ; Zhu JH; Huang SY; Cui Z; He J; Jia WH
Tumour Biol; 2014 Dec; 35(12):12509-17. PubMed ID: 25204673
[TBL] [Abstract][Full Text] [Related]
48. Association of single-nucleotide polymorphisms in tumour necrosis factor and human leukocyte antigens genes with type 1 diabetes.
Osman AE; Brema I; AlQurashi A; Al-Jurayyan A; Bradley B; Hamza MA
Int J Immunogenet; 2021 Aug; 48(4):326-335. PubMed ID: 34018329
[TBL] [Abstract][Full Text] [Related]
49. MHC loci affecting cervical cancer risk: distinguishing the effects of HLA-DQB1 and non-HLA genes TNF, LTA, TAP1 and TAP2.
Ivansson EL; Magnusson JJ; Magnusson PK; Erlich HA; Gyllensten UB
Genes Immun; 2008 Oct; 9(7):613-23. PubMed ID: 18650831
[TBL] [Abstract][Full Text] [Related]
50. A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.
Cree BA; Rioux JD; McCauley JL; Gourraud PA; Goyette P; McElroy J; De Jager P; Santaniello A; Vyse TJ; Gregersen PK; Mirel D; Hafler DA; Haines JL; Pericak-Vance MA; Compston A; Sawcer SJ; Oksenberg JR; Hauser SL; ;
PLoS One; 2010 Jun; 5(6):e11296. PubMed ID: 20593013
[TBL] [Abstract][Full Text] [Related]
51. The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population.
Zhong C; Gragert L; Maiers M; Hill BT; Garcia-Gomez J; Gendzekhadze K; Senitzer D; Song J; Weisenburger D; Goldstein L; Wang SS
Leuk Lymphoma; 2019 Dec; 60(12):2899-2908. PubMed ID: 31215275
[TBL] [Abstract][Full Text] [Related]
52. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome.
Warzocha K; Ribeiro P; Bienvenu J; Roy P; Charlot C; Rigal D; Coiffier B; Salles G
Blood; 1998 May; 91(10):3574-81. PubMed ID: 9572991
[TBL] [Abstract][Full Text] [Related]
53. Immunogenetic biomarkers in inflammatory bowel diseases: role of the IBD3 region.
Muro M; López-Hernández R; Mrowiec A
World J Gastroenterol; 2014 Nov; 20(41):15037-48. PubMed ID: 25386052
[TBL] [Abstract][Full Text] [Related]
54. TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children.
Rossi E; Basso D; Zambon CF; Navaglia F; Greco E; Pelloso M; Artuso S; Padoan A; Pescarin M; Aita A; Bozzato D; Moz S; Cananzi M; Guariso G; Plebani M
PLoS One; 2015; 10(4):e0123244. PubMed ID: 25915602
[TBL] [Abstract][Full Text] [Related]
55. C677T and A1298C polymorphisms of methylene tetrahydrofolate reductase in non-Hodgkin lymphoma: southeast Iran.
Mashhadi MA; Miri-Moghaddam E; Arbabi N; Bazi A; Heidari Z; Sepehri Z; Karimkoshte A; Rezvan A; Hashemi SM
Tumori; 2018 Aug; 104(4):280-284. PubMed ID: 28430351
[TBL] [Abstract][Full Text] [Related]
56. Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk.
Gaudet MM; Egan KM; Lissowska J; Newcomb PA; Brinton LA; Titus-Ernstoff L; Yeager M; Chanock S; Welch R; Peplonska B; Trentham-Dietz A; Garcia-Closas M
Hum Genet; 2007 May; 121(3-4):483-90. PubMed ID: 17216494
[TBL] [Abstract][Full Text] [Related]
57. Genetic fixity in the human major histocompatibility complex and block size diversity in the class I region including HLA-E.
Romero V; Larsen CE; Duke-Cohan JS; Fox EA; Romero T; Clavijo OP; Fici DA; Husain Z; Almeciga I; Alford DR; Awdeh ZL; Zuñiga J; El-Dahdah L; Alper CA; Yunis EJ
BMC Genet; 2007 Apr; 8():14. PubMed ID: 17430593
[TBL] [Abstract][Full Text] [Related]
58. C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma.
Song H; Tong D; Cha Z; Bai J
Mol Biol Rep; 2012 Sep; 39(9):8629-35. PubMed ID: 22707196
[TBL] [Abstract][Full Text] [Related]
59. Associations between tumor necrosis factor-alpha and lymphotoxin-alpha polymorphisms and idiopathic recurrent miscarriage.
Zammiti W; Mtiraoui N; Khairi H; Gris JC; Almawi WY; Mahjoub T
Reproduction; 2008 Mar; 135(3):397-403. PubMed ID: 18299433
[TBL] [Abstract][Full Text] [Related]
60. Associations between genetic variants in immunoregulatory genes and risk of non-Hodgkin lymphoma in a Chinese population.
Ye X; Zhao K; Wu C; Hu P; Fu H
Oncotarget; 2017 Feb; 8(6):10450-10457. PubMed ID: 28060727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
